Longboard Pharmaceuticals Inc (LBPH)
18.84
+0.94
(+5.25%)
USD |
NASDAQ |
May 31, 16:00
18.86
+0.02
(+0.08%)
After-Hours: 20:00
Longboard Pharmaceuticals Net Income (Quarterly): -14.99M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.99M |
| December 31, 2023 | -15.03M |
| September 30, 2023 | -12.93M |
| June 30, 2023 | -15.00M |
| March 31, 2023 | -11.46M |
| December 31, 2022 | -11.34M |
| September 30, 2022 | -11.60M |
| June 30, 2022 | -11.41M |
| March 31, 2022 | -9.597M |
| Date | Value |
|---|---|
| December 31, 2021 | -8.773M |
| September 30, 2021 | -6.345M |
| June 30, 2021 | -6.98M |
| March 31, 2021 | -5.699M |
| December 31, 2020 | -10.11M |
| September 30, 2020 | -2.55M |
| June 30, 2020 | -1.567M |
| March 31, 2020 | -0.174M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.03M
Minimum
Dec 2023
-0.174M
Maximum
Mar 2020
-9.15M
Average
-10.11M
Median
Dec 2020
Net Income (Quarterly) Benchmarks
| SIGA Technologies Inc | 10.28M |
| Mersana Therapeutics Inc | -19.31M |
| Pulmonx Corp | -13.75M |
| Maravai LifeSciences Holdings Inc | -12.08M |
| Caribou Biosciences Inc | -41.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 18.11M |
| EPS Diluted (Quarterly) | -0.42 |
| Enterprise Value | 411.46M |
| Earnings Yield | -11.89% |